
    
      In this trial, investigators will infuse donor bone marrow mesenchymal stromal cells
      intravenously, as a treatment for pediatric Crohn's disease or ulcerative colitis that has
      not responded to conventional therapies. Mesenchymal stromal cells support the development of
      blood cells within the bone marrow. They have also been demonstrated to travel to areas of
      inflammation, to alter immune responses, to decrease pro-inflammatory cytokines, and to
      promote tissue repair. Infusion of these cells does not lead to rejection. These properties
      lead investigators to hypothesize that that these may be they may be beneficial in treating
      inflammatory bowel disease.

      Investigators will culture donated bone marrow mesenchymal stromal cells in a unique
      automated system, and infuse the cells in a fresh, replicating stage of growth. This study is
      to test the safety and tolerability of donor mesenchymal stromal cells in children with
      Inflammatory Bowel Disease.
    
  